This search looks for keywords in all of the website’s content. Search tips
Filter by
- Agenda(1916)
- Annex to CHMP highlights(367)
- Annual Report(94)
- Application withdrawal assessment report(276)
- Committee meeting report(882)
- COVID-19 vaccine safety update(71)
- Direct healthcare professional communication(122)
- EPAR - All authorised presentations(1980)
- EPAR - Amended Product Information(1)
- EPAR - Assessment report - Variation(2711)
- EPAR - Assessment report on maintenance of orphan designation - Initial authorisation(141)
- EPAR - Assessment report on maintenance of orphan designation - Post-authorisation(42)
- EPAR - Conditions imposed on member states for safe and effective use(112)
- EPAR - Overview(1976)
- EPAR - Paediatric investigation plan compliance statement(89)
- EPAR - Procedural steps taken and scientific information after authorisation(1887)
- EPAR - Procedural steps taken before authorisation(484)
- EPAR - Product Information(1976)
- EPAR - Public assessment report(1551)
- EPAR - Risk-management-plan summary(1144)
- EPAR - Scientific conclusion(1358)
- EPAR - Scientific Discussion(504)
- EPAR - Scientific Discussion - Variation(188)
- EPAR - Steps taken after authorisation when a cutoff date has been used(170)
- Herbal - Call for data(293)
- Herbal - Herbal monograph(118)
- Herbal - HMPC assessment report(476)
- Herbal - HMPC opinion on a European Union herbal monograph(247)
- Herbal - List of references supporting the assessment report(462)
- Herbal - Overview of comments received during consultation(164)
- Herbal - Summary of assessment report for the public(120)
- Herbal – European Union herbal monograph(330)
- Herbal – European Union list entry(19)
- Leaflet(72)
- Maximum Residue Limits - Divergent opinion(2)
- Maximum Residue Limits - Opinion(88)
- Maximum Residue Limits - Summary of opinion(14)
- Medicine QA(456)
- Medicines under additional monitoring(24)
- Minutes(1250)
- Newsletter(299)
- Opinion outside EU - All presentations(14)
- Opinion outside EU - Assessment report - Variation(9)
- Opinion outside EU - Medicine questions and answers(1)
- Opinion outside EU - Procedural steps taken and scientific information after opinion(11)
- Opinion outside EU - Procedural steps taken before opinion(3)
- Opinion outside EU - Product information(15)
- Opinion outside EU - Public assessment report(12)
- Opinion outside EU - Risk-management-plan summary(11)
- Opinion outside EU - Scientific discussion(4)
- Opinion outside EU - Summary for the public(15)
- Opinion outside EU - Summary of opinion(3)
- Opinion outside EU - Summary of opinion - Initial authorisation(9)
- Opinion outside EU - Withdrawal assessment report(1)
- Orphan designation(2420)
- Orphan review(106)
- Overview of comments(330)
- Parallel distribution(1)
- Periodic safety update single assessment(2763)
- PIP - Notification of discontinuation of a paediatric development which is covered by an agreed PIP decision(109)
- PIP - Paediatric-investigation-plan summary(93)
- PIP decision(5491)
- Position statement(29)
- PRAC recommendation on signal(164)
- Presentation(5308)
- Press Release(1708)
- Procurement(73)
- Public Statement(485)
- Recommendation on medication errors(26)
- Recruitment(38)
- Referrals document(2782)
- Regulatory and procedural guideline(723)
- Report(1620)
- Scientific guideline(2465)
- Standard Operating Procedure - SOP(129)
- Summary of opinion(1223)
- Summary of opinion - Initial authorisation(1675)
- Supply shortage(58)
- Template or form(480)
- Withdrawal letter(290)
- Work Instruction - WIN(61)
- Work programme(151)
- (-)Maximum Residue Limits - Report(804)
- (-)Other(4061)
- Advanced therapies(99)
- Antimicrobial resistance(45)
- Biologicals(3)
- Biosimilars(7)
- Brexit(6)
- Careers(0)
- Clinical trials(93)
- Compassionate use(8)
- Compliance and inspections(78)
- Corporate(11)
- COVID-19(43)
- Data on medicines(112)
- Early access(12)
- Fees(4)
- Generic and hybrid medicines(18)
- Governance(206)
- Innovation(61)
- Maximum residue limit(808)
- Medication error(3)
- Medicines(1656)
- Medicines for use outside the EU(9)
- Medicine shortages(15)
- Mpox(4)
- Paediatrics(367)
- Parallel distribution(2)
- Pharmacovigilance(326)
- Procurement(49)
- Product information(136)
- Quality of medicines(22)
- Rare diseases(203)
- Referrals(35)
- Regulatory and procedural guidance(350)
- Research and development(38)
- Scientific advice(32)
- Scientific guidelines(35)
- SME(17)
- Vaccines(36)
- Veterinary limited markets(6)
Search results (4865)
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level
English (EN) (187.89 KB - PDF)
Sodium salicylate (poultry other than turkey): European Public MRL Assessment Report (EPMAR) - CVMP
English (EN) (275.49 KB - PDF)
DARWIN EU Advisory Board: Membership
English (EN) (85.92 KB - PDF)
Declaration of interests: Marko Banjanin
English (EN) (47.21 KB - PDF)
Record of data processing activity for Risk Management Plans Publication Process
English (EN) (153.96 KB - PDF)
European Medicines Agency’s Data Protection Notice For the Risk Management Plans Publication Process
English (EN) (207.5 KB - PDF)
Anonymisation report form instructions
English (EN) (474.2 KB - PDF)
Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions
English (EN) (207.19 KB - PDF)
Remote RP activities
English (EN) (88.11 KB - PDF)
EVVet3 EVWeb Production – Release notes
English (EN) (574.06 KB - PDF)